Drugs / tPA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02453373 Background | Jan 2017 → Jun 2023 | brain ischemia, stroke disorder | Life Recovery Systems | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02453373 ↗ |
| Route | Intravenous | “tPA will be administered intravenously if indicated” NCT02453373 ↗ |